2 - TI Pharma

Figure 3. Postprandial responses at baseline and at 14 day of intervention. Panel A: Glucose concentrations.
Panel B: Insulin concentrations. Panel C: C-peptide concentrations. Panel D: Glucagon-like peptide (GLP)-
1 concentrations. Panel E: Glucose-dependent insulinotropic polypeptide (GIP) concentrations. Panel F:
Glucagon concentrations. Straight line with black squares denotes pre-treatment. Dotted line with open
circles represents on-treatment. Box-and-Whisker plots with absolute change in area under the curve
(AUC) from baseline are shown. Between-group changes from baseline were tested by Kruskal-Wallis test
with trend analysis (indicated by top line). Posthoc tests were done by Mann-Whitney U with Bonferroni
correction for multiple testing (indicated by line with brackets). ***P